Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SI | P14410 | 1/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL2849274 | 1.00 | THRB (0.52) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL1088472 | 0.93 | THRB (0.47) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL25369507 | 0.91 | THRB (0.45) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL1244633 | 0.90 | THRB (0.65) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL7249997 | 0.90 | THRB (0.65) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL19551091 | 0.85 | THRB (0.55) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL27495305 | 0.85 | THRB (0.45) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL8854364 | 0.85 | ALOX15 (0.60) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Methacrylic Acid SCHEMBL14743933 | 0.85 | THRB (0.41) | THRBALDH1A1TSHRHSD17B10LMNA | |
| Triethylene Glycol SCHEMBL1922505 | 0.85 | ALDH1A1 (0.50) | THRBALDH1A1TSHRHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116835903-B | Shrinkage-reducing alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12594281-B2 | Pharmaceutical dosage forms and methods of use | EMALEX BIOSCIENCES, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-20250288594-A1 | PHARMACEUTICAL DOSAGE FORMS AND METHODS OF USE | EMALEX BIOSCIENCES, INC. | 2025-09-18 | — | — | US | claimed |
| EP-4617295-A1 | SURFACTANT, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Research Institute of Chemical Industry Co., Ltd. (CN) | 2025-09-17 | — | — | EP | claimed |
| US-20250270397-A1 | SURFACTANT, PREPARATION METHOD THEREFOR AND USE THEREOF | ZHEJIANG LANTIAN ENVIRONMENTAL PROTECTION HI-TECH CO., LTD. (CN) | 2025-08-28 | — | — | US | claimed |
| US-12398227-B2 | Polymer additive comprising zwitterionic moieties for vinylidene fluoridepolymer based membranes | SYENSQO SA (BE) | 2025-08-26 | — | — | US | claimed |
| CN-120118223-A | Method for adjusting particle size of fluorine-containing polymer emulsion | 浙江蓝天环保高科技股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120118250-A | Surfactant, preparation method and application thereof | 浙江蓝天环保高科技股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120118232-A | Preparation method and application of fluorine-containing polymer emulsion | 浙江蓝天环保高科技股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-4076714-B1 | POLYMER ADDITIVE COMPRISING ZWITTERIONIC MOIETIES FOR VINYLIDENE FLUORIDE POLYMER BASED MEMBRANES | SYENSQO SA (BE) | 2025-05-21 | — | — | EP | claimed |
| US-20030225185-A1 | Encapsulated pigment for ink-jet ink formulations nad methods of producing same | LEXMARK INTERNATIONAL, INC | 2003-12-04 | — | — | US | claimed |
| US-6533503-B2 | Polymerizable monomer or curable resin, a polymerization initiator and/or curing accelerator that can be activated and/or released thermally at a temperature above 30 degrees Celcius, and optional filler; pot life and faster curing time | HILTI AKTIENGESELLSCHAFT | 2003-03-18 | — | — | US | claimed |
| JP-2001524740-A | — | — | 2001-12-04 | — | — | JP | claimed |
| US-20010018880-A1 | Mortar composition, curable by frontal polymerization, and a method for fastening tie bars | HILTI AKTIENGESELLSCHAFT (LI) | 2001-09-06 | — | — | US | claimed |
| EP-1040529-A1 | A PROTON EXCHANGE MEMBRANE FUEL CELL POWER SYSTEM | Avista Labs (US) | 2000-10-04 | — | — | EP | claimed |
| WO-1999027599-A1 | A PROTON EXCHANGE MEMBRANE FUEL CELL POWER SYSTEM | AVISTA LABS (US) | 1999-06-03 | — | — | WO | claimed |
| US-5397675-A | Alkali developable photosensitive resin composition containing oil-soluble diazo resin | NIPPON PAINT CO., LTD. (JP) | 1995-03-14 | — | — | US | claimed |
| EP-0581311-A2 | Alkali developable photosensitive resin composition | Nippon Paint Co., Ltd. (JP) | 1994-02-02 | — | — | EP | claimed |
| US-4824681-A | HYDROPHOBIC POLYMER AND HYDROPHOBIC PLASTICIZER | WARNER-LAMBERT COMPANY (US) | 1989-04-25 | — | — | US | claimed |
| EP-0272220-A2 | Encapsulated sweetener composition for use with chewing gum and edible products | WARNER-LAMBERT COMPANY (US) | 1988-06-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594281-B2 | Pharmaceutical dosage forms and methods of use | TAS2R5, TACR1, CHRM5 | THRB 1144/4885ALDH1A1 615/4885TSHR 101/4885 |
| US-20250288594-A1 | PHARMACEUTICAL DOSAGE FORMS AND METHODS OF USE | MC2R, PTGDR, HTR5A | THRB 463/4885ALDH1A1 801/4885TSHR 135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.